Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma
Clinical trial NCT00112827 · COMPLETED
Trial details
- NCT number
- NCT00112827
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2019-02-15
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.